Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model-Reference-Cited by-同舟云学术

Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model

Published:2021-10-31 Issue: Volume: Page:
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Wang Bo,He Zhihua^ORCID,Yu Hao,Ou Ziwei,Chen Junyu,Yang Meihua,Fan Xinxiang,Lin Tianxin,Huang Jian^ORCID

Funder

National Natural Science Foundation of China

Science and Technology Program of Guangzhou

Pearl River S&T Nova Program of Guangzhou

Fundamental Research Funds for Young Teachers in the Higher Education Institutions of China

Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University

Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology

Key Science Research Projects of Gannan Medical University in 2018

Science and Technology Plan Project of Jiangxi Provincial Health Committee

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-03063-7.pdf

Reference41 articles.

1. Alexandroff AB, Jackson AM, O’Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694. https://doi.org/10.1016/S0140-6736(98)07422-4

2. Pettenati C, Ingersoll MA (2018) Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat Rev Urol 15:615–625. https://doi.org/10.1038/s41585-018-0055-4

3. Babjuk M, Burger M, Comperat EM et al (2019) European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In situ) - 2019 update. Eur Urol. https://doi.org/10.1016/j.eururo.2019.08.016

4. Kobayashi M, Fujiyama N, Tanegashima T et al (2021) Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-021-03032-0

5. Kamat AM, Colombel M, Sundi D et al (2017) BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nat Rev Urol 14:244–255. https://doi.org/10.1038/nrurol.2017.16

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PA-MSHA improves prognosis of patients undergoing radical cystectomy: a retrospective cohort study using inverse probability of treatment weighting;Frontiers in Immunology;2024-06-25

2. Trends in Anti-Tumor Effects of Pseudomonas aeruginosa Mannose-Sensitive-Hemagglutinin (PA-MSHA): An Overview of Positive and Negative Effects;Cancers;2024-01-25

3. Co-delivery of oxaliplatin prodrug liposomes with Bacillus Calmette-Guérin for chemo-immunotherapy of orthotopic bladder cancer;Journal of Controlled Release;2024-01

4. Biological function, regulatory mechanism, and clinical application of mannose in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant;Cancer Immunology Research;2023-10-17